Is abrdn FCO a once in a decade opportunity 136 20260511 HBIO Harvard Bioscience misses Q4 2025 EPS estimates shares rise nearly 2 percent on optimistic investor outlook BN Brookfield posts soft Q4 2025 results on large EPS miss and doubledigit revenue decline shares edge lower CME Group CME